Demystified . . . Tissue microarray technology

Journal of Clinical Pathology - Molecular Pathology

Volumn 56, Issue 4, 2003, Pages 198-204

  Packeisen, J ^b   Korsching, E ^c   Herbst, H ^c   Boecker, W ^c   Buerger, H ^a,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Andreas Bannowsky Ltd   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CANCER CELL CULTURE; DNA MICROARRAY; GENOMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MATHEMATICAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; REVIEW;

ANIMALS; BIOPSY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUALITY CONTROL; RESEARCH; TUMOR CELLS, CULTURED;

EID: 0043069476     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.56.4.198     Document Type: Review

References (29)

1. Battifora H. The multi-tumour (sausage) tissue block. Novel method for immunohistochemical antibody testing. Lab Invest 1986;55:244-8.
2. Chan JK, Wong CS, Ku WT. Reflections on the use of controls in immunohistochemistry and proposal for application of a multitissue spring-roll control block. Ann Diagn Pathol 2000;4:329-66.
3. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens [see comments]. Nat Med 1998;4:844-7.
4. Bubendorf L, Nocito A, Moch H, et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001;195:72-9.
5. Moch H, Kononen T, Kallioniemi OP, et al. Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001;8:14-20.
6. Journal of Pathology. http://www.interscience.wiley.com/pages/0022-3417/license.html. J Pathol 2002.
7. von Wasielewski R, Mengel M, Wiese B, et al. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 2002;118:675-82.
8. Simon R, Nocito A, Hübscher T, et al. Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 2001;93:1141-6.
9. Simon R, Struckmann K, Schraml P, et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002;21:2476-83.
10. Korsching E, Packeisen J, Agelopaulos K, et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer-integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest 2002;82:1525-33.
11. Fejzo MS, Slamon DJ. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol 2001;159:1645-50.
12. Parker RL, Huntsman DG, Lesack DW, et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol 2002;117:723-8.
13. Hsu FD, Nielsen TO, Alkushi A, et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002;15:1374-80.
14. Mengel M, von Wasielewski R, Wiese B, et al. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 2002;198:292-9.
15. Packeisen J, Buerger H, Krech R, et al. Multi tissue arrays - a new approach for quality control in immunohistochemistry. J Clin Pathol 2002;55:613-15.
16. van Diest PJ, Baak JP, Matze Cok P, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project [see comments]. Hum Pathol 1992;23:603-7.
17. van de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002;161:1991-6.
18. Perou C, Sorlie T, Eisen M, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
19. Sorlie T, Perou C, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
20. Alizadeh AA, Ross DT, Perou C, et al. Towards a novel classification of human malignancies based on gene expression. J Pathol 2001;195:41-52.
21. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
22. Ince TA, Weinberg RA. Functional genomics and the breast cancer problem. Cancer Cell 2002;1:23-5.
23. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
24. van't Heer L, Dai H, van de Vijver M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.
25. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
26. Liu CL, Prapong W, Natkunam Y, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002;161:1557-65.
27. Brandt B, Roetger A, Bidart JM, et al. Early placental insulin-like growth factor (pro-Epil) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential. Cancer Res 2002;62:1020-4.
28. Sauter G, Mirlacher M. Tissue microarrays for predictive molecular pathology. J Clin Pathol 2002;55:575-6.
29. Torhorst J Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-56.